Chad Jackson

Chad Jackson, Ph.D. is currently serving as a Board Trustee at Earlham College and as the Senior Director of the Preclinical Translational Research Program at Foundation Fighting Blindness. Additionally, Chad is a Board Member (Vice Chair) at Seeding Labs and was previously the Chairman of the Board of Directors at C2 Genomics. With a background in molecular neuropharmacology and a doctorate in Molecular & Systems Pharmacology from Emory University, Chad has extensive experience in overseeing research programs and providing science and technology support in various organizations, including governmental agencies and start-up companies.